Identification of Chemical Scaffolds Targeting Drug-Resistant and Latent <i>Mycobacterium tuberculosis</i> through High-Throughput Whole-Cell Screening.

Perveen, Summaya; Negi, Anjali; Saini, Sapna; Gangwar, Anjali; Sharma, Rashmi

Identification of Chemical Scaffolds Targeting Drug-Resistant and Latent Mycobacterium tuberculosis through High-Throughput Whole-Cell Screening.

Perveen, Summaya; Negi, Anjali; Saini, Sapna; Gangwar, Anjali; Sharma, Rashmi.

Afiliación

Perveen S; Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu 180001, India.
Negi A; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Saini S; Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu 180001, India.
Gangwar A; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Sharma R; Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu 180001, India.

ACS Infect Dis ; 10(2): 513-526, 2024 02 09.

Article en En | MEDLINE | ID: mdl-38238154

Asunto(s)

Tuberculosis Latente; Mycobacterium tuberculosis; Tuberculosis; Humanos; Antituberculosos/química; Isoniazida/farmacología; Pruebas de Sensibilidad Microbiana; Tuberculosis/microbiología

Palabras clave

H37Rv; drug discovery; drug resistance; phenotypic whole-cell screening; tuberculosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis Asunto principal: Tuberculosis / Tuberculosis Latente / Mycobacterium tuberculosis Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: ACS Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google